Skip to main content

Table 4 Incidence of prostate cancer upstaging regarding T stage after mpMRI

From: Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience

cT1–2 Tumors

n

Tumor upstaging (n)

Percentage of tumor upstaging

Gleason score < 7

42

19

45.2%

Gleason score 7

40

24

60%

Gleason score > 7

15

8

53%

PSA level < 10 ng/ml

44

22

50%

PSA level 10–20 ng/ml

30

16

53.3%

PSA level > 20 ng/ml

23

17

73.9%

  1. Incidence of prostate cancer upstaging regarding T stage after mpMRI depending on initial serum PSA level and the Gleason score in patients initially staged as cT1–cT2 (n = 97).
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us